Home Current Issue Previous Issues Published Ahead-of-Print Supplements Collections Podcasts Video Journal Info
Skip Navigation LinksHome > May 2013 - Volume 72 - Issue 5 > Safety and Validity of Mechanical Thrombectomy and Thromboly...
Neurosurgery:
doi: 10.1227/NEU.0b013e318285c1d3
Research-Human-Clinical Studies

Safety and Validity of Mechanical Thrombectomy and Thrombolysis on Severe Cerebral Venous Sinus Thrombosis

Li, Guangwen MD*,‡; Zeng, Xianwei MD*,§; Hussain, Mohammed PhD*,‖; Meng, Ran MD‡,¶; Liu, Yi PhD; Yuan, Kevin PhD; Sikharam, Chaitanya PhD; Ding, Yuchuan PhD; Ling, Feng MD; Ji, Xunming MD, PhD

Collapse Box

Abstract

BACKGROUND: Although the majority of patients with cerebral venous sinus thrombosis (CVST) obtain an optimistic clinical outcome after heparin or warfarin treatment, there remains a subgroup of patients who do not respond to conventional anticoagulation treatment. These patients, especially younger people, as documented by hospital-based studies, have a high morbidity and mortality rate.

OBJECTIVE: To verify the safety and efficacy of a dual mechanical thrombectomy with thrombolysis treatment modality option in patients with severe CVST.

METHODS: Fifty-two patients diagnosed with CVST were enrolled and treated with mechanical thrombectomy combined with thrombolysis. Patients underwent urokinase 100 to 1500 × 103 IU intravenous sinus injection via a jugular catheter after confirming diagnoses of CVST by using either magnetic resonance imaging/magnetic resonance venography or digital subtract angiography. Information obtained on the patients included recanalization status of venous sinuses as evaluated by magnetic resonance venography or digital subtract angiography at admission, during operation, and at 3- and 6-month follow-up after treatment.

RESULTS: The percentage of patients that showed complete and partial recanalization were 87% and 6%, respectively, after mechanical thrombectomy combined with thrombolysis treatment; 8% of the patients showed no recanalization. The modified Rankin Scale scores were 1.0 ± 0.9, 0.85 ± 0.63, and 0.37 ± 0.53 for discharge, and 3- and 6-month follow-up, respectively. A total of 6 patients died despite receiving aggressive treatment. No cases of relapse occurred after 3 to 6 months of follow-up.

CONCLUSION: Thrombectomy combined with thrombolysis is a safe and valid treatment modality to use in severe CVST cases or in intractable patients that have shown no adequate response to antithrombotic drugs.

ABBREVIATIONS: CVST, cerebral venous sinus thrombosis

DSA, digital subtract angiography

mRS, modified Rankin Scale

MRV, magnetic resonance venography

Copyright © by the Congress of Neurological Surgeons

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.